Transfection Reagents and Equipment Market Report Trends

Posted September 3, 2021 by kirtiarora has released a new market research on the “Transfection Reagents and Equipment Market” that reveals aspects of possible growth and development.

Transfection Reagents and Equipment market is expected to grow from USD 10.46 billion in 2019 to USD 17.87 billion by 2026 at a CAGR of 7.95% from 2020 to 2026.
Transfection is a technique that is employed to insert genetic material like DNA or RNA, into mammalian cells. Transfection reagents and equipment are utilized in this process, wherein reagents contain the genetic material and equipment used as a delivery for the genetic material. This introduction of genetic material into the specified cells are often administered by various chemical, biological, or physical methods. The growth of the market is often attributed to increasing technological advancements in transfections equipment and rising research and development spending alongside research activities by pharmaceutical and biotechnology companies. Moreover, rising demand for synthetic genes is probably going to feature new opportunities for the worldwide market within the forecast period. This growth is often attributed to factors like advancements in transfection technology, global alliances among leading research institutes to trigger drug discovery, increase in R&D spending and research activities by pharmaceutical and biotechnology companies, increase in demand for synthetic genes, and rising incidence of cancer. Moreover, the development of huge scale transfections, rising demand for protein therapeutics, and emerging markets across India and China are likely to make opportunities for players operating within the market. The global market is segregated on the basis of Product as Reagents and Instruments.
View Complete Report: @
The global Transfection Reagents and Equipment market has been segmented as below:
By Product
By Method
Calcium Phosphate
By End-User
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
By Application
Biomedical Research
Gene Expression Studies
Cancer Research
Transgenic Model
Protein Production
Therapeutic Delivery
By Region
North America
Asia Pacific
Rest of The World
Competitive Rivalry
Thermo Fisher Scientific Inc. (Life Technologies), Promega Corporation, Qiagen N.V., F. Hoffmann-La Roche Ltd, Bio–Rad Laboratories, Inc., Maxcyte, Inc., Lonza Group Ltd., Merck KGaA, Polyplus-Transfection Sa, Mirus Bio LLC., and others are among the major players in the market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
Request a Sample of this Report: @
Explore other reports from ”Healthcare” sector @

Contact Us:
SRR residency Mig-59,
7th phase Kphb colony
Near prathibha school
Hyderabad, 500072
s[email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By market reports library
Country India
Categories Business
Last Updated September 3, 2021